Aegerion Pharmaceuticals, Inc. - Overview

400 PM ET on Aug 7, 2015. Delayed at least 20 minutes. Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Press Releases View all. Aug 5, 2015. Aegerion Pharmaceuticals Announces Second Quarter 2015 Financial Results. Jul 27, 2015. Aegerion Pharmaceuticals Announces Leadership Changes to Support the Next Stage of Growth. Jul 13, 2015. Aug 7, 2015 at 400 PM ET.

OVERVIEW

The site ir.aegerion.com currently has an average traffic classification of zero (the smaller the more traffic). We have examined eighteen pages within the site ir.aegerion.com and found forty-five websites associating themselves with ir.aegerion.com. There is two mass networking sites retained by ir.aegerion.com.
Pages Crawled
18
Links to this site
45
Social Links
2

IR.AEGERION.COM TRAFFIC

The site ir.aegerion.com has seen alternating amounts of traffic for the whole of the year.
Traffic for ir.aegerion.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.aegerion.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.aegerion.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO DOMAIN

WHAT DOES IR.AEGERION.COM LOOK LIKE?

Desktop Screenshot of ir.aegerion.com Mobile Screenshot of ir.aegerion.com Tablet Screenshot of ir.aegerion.com

IR.AEGERION.COM SERVER

We discovered that a single root page on ir.aegerion.com took zero milliseconds to stream. Our web crawlers could not observe a SSL certificate, so in conclusion our parsers consider this site not secure.
Load time
0 secs
SSL
NOT SECURE
Internet Protocol
206.200.251.19

HTML TITLE

Aegerion Pharmaceuticals, Inc. - Overview

DESCRIPTION

400 PM ET on Aug 7, 2015. Delayed at least 20 minutes. Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Press Releases View all. Aug 5, 2015. Aegerion Pharmaceuticals Announces Second Quarter 2015 Financial Results. Jul 27, 2015. Aegerion Pharmaceuticals Announces Leadership Changes to Support the Next Stage of Growth. Jul 13, 2015. Aug 7, 2015 at 400 PM ET.

PARSED CONTENT

The site ir.aegerion.com has the following in the site, "400 PM ET on Aug 7, 2015." We noticed that the website also stated " Delayed at least 20 minutes." It also stated " Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Aegerion Pharmaceuticals Announces Second Quarter 2015 Financial Results. Aegerion Pharmaceuticals Announces Leadership Changes to Support the Next Stage of Growth. Aug 7, 2015 at 400 PM ET."

ANALYZE MORE WEBSITES

American Financial Group, Inc. AFG - Investor Relations

American Financial Group, Inc. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. 1 513 352 9230 fax.

Investor Centre Aggreko plc

Results, Reports and Presentations. Our Approach to Corporate Governance. Health, Safety and Environment. Results, Reports and Presentations.

AGL Resources - Investor Relations

Click here for full shareholder services contact information.

Investor Relations Home - Investor Relations - American Capital Agency Corp

00 Net Book Value Per Common Share. 20 per Common Share for July 2015. Will Report Second Quarter 2015 Results on July 27; Shareholder Call Scheduled for July 28.